We are live on ! Find out more
HRTX icon

Heron Therapeutics
HRTX

200 hedge funds and large institutions have $1.07B invested in Heron Therapeutics in 2021 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 66 increasing their positions, 57 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

23% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 26

21% more call options, than puts

Call options by funds: $12.5M | Put options by funds: $10.4M

16% more repeat investments, than reductions

Existing positions increased: 66 | Existing positions reduced: 57

8.95% more ownership

Funds ownership: 106.46% → 115.41% (+9%)

2% more funds holding

Funds holding: 197 → 200 (+3)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

8% less capital invested

Capital invested by funds: $1.16B → $1.07B (-$87.7M)

Holders
200
Holders Change
+3
Holders Change %
+1.52%
% of All Funds
3.08%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
32
Increased
66
Reduced
57
Closed
26
Calls
$12.5M
Puts
$10.4M
Net Calls
+$2.14M
Net Calls Change
+$80K

Top Buyers

1
UOC
UBS O'Connor
Illinois
+$16.8M
2
Citadel Advisors
Citadel Advisors
Florida
+$15.8M
3
State Street
State Street
Massachusetts
+$12.3M
4
Millennium Management
Millennium Management
New York
+$10.3M
5
SCM
Suvretta Capital Management
New York
+$10.2M

Top Sellers

1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$17.1M
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$8.01M
3
GLA
Great Lakes Advisors
Illinois
-$7.94M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$5.24M
5
PAM
Panagora Asset Management
Massachusetts
-$4.13M
Name Holding Trade Value Shares
Change 		Change in
Stake
Franklin Resources
1
Franklin Resources
California
$109M -$133K -12,997 -0.1%
Vanguard Group
2
Vanguard Group
Pennsylvania
$87.7M +$1.11M +108,753 +1%
UOC
3
UBS O'Connor
Illinois
$75.6M +$16.8M +1,641,084 +25%
BBA
4
Baker Bros. Advisors
New York
$74.2M – – –
TCM
5
Tang Capital Management
California
$71.1M -$1.27M -124,159 -2%
State Street
6
State Street
Massachusetts
$70.2M +$12.3M +1,200,504 +18%
BlackRock
7
BlackRock
New York
$70.1M +$95.3K +9,333 +0.1%
ACH
8
ArrowMark Colorado Holdings
Colorado
$58.5M -$158K -15,470 -0.2%
JP Morgan Chase
9
JP Morgan Chase
New York
$57.1M +$9.73M +952,969 +18%
PHS
10
PFM Health Sciences
California
$32.1M +$5.3M +518,802 +17%
PCM
11
Palisade Capital Management
New Jersey
$27.7M +$5.54M +542,589 +22%
SI
12
Sofinnova Investments
California
$26.8M +$6.45M +632,172 +27%
SCM
13
Suvretta Capital Management
New York
$22.7M +$10.2M +995,900 +67%
Goldman Sachs
14
Goldman Sachs
New York
$17.5M +$3.23M +316,554 +20%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$15.6M +$1.01M +99,233 +6%
Citadel Advisors
16
Citadel Advisors
Florida
$15.5M +$15.8M +1,552,390 +1,105%
Wellington Management Group
17
Wellington Management Group
Massachusetts
$15M -$8.01M -784,149 -32%
RCAMU
18
Rothschild & Co Asset Management US
Connecticut
$12.6M +$3.12M +305,321 +28%
D.E. Shaw & Co
19
D.E. Shaw & Co
New York
$12.3M -$831K -81,438 -6%
CWG
20
C WorldWide Group
Denmark
$11M – – –
Millennium Management
21
Millennium Management
New York
$9.17M +$10.3M +1,004,798 New
Northern Trust
22
Northern Trust
Illinois
$8.78M -$50.7K -4,967 -0.5%
Norges Bank
23
Norges Bank
Norway
$7.39M +$970 +95 +0%
New York State Common Retirement Fund
24
New York State Common Retirement Fund
New York
$7.33M +$1.51M +147,474 +23%
IHAM
25
Integral Health Asset Management
New York
$6.85M +$3.47M +340,000 +83%
1
2 3 4 5

HRTX Hedge Fund Activity: Q4 2021 in Review

200 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Heron Therapeutics (HRTX) for Q4 2021, worth a combined $1.07B — down 7.6% from $1.16B a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new HRTX positions and 26 closed out — a net gain of 6 holders — while 66 added to existing stakes and 57 trimmed.

The largest buyer was UBS O'Connor, adding an estimated $16.8M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $17.1M sold.

  • 200 institutional investors held Heron Therapeutics (HRTX) as of Q4 2021, up from 197 in Q3 2021.
  • Funds reported $1.07B of Heron Therapeutics stock for Q4 2021, down 7.6% quarter-over-quarter.
  • 32 funds opened new Heron Therapeutics positions in Q4 2021 and 26 closed out, a net change of +6 holders.
  • The largest Heron Therapeutics buyer in Q4 2021 was UBS O'Connor, an estimated $16.8M added.
  • The largest Heron Therapeutics seller in Q4 2021 was Point72 Asset Management, an estimated $17.1M sold.

Based on aggregated 13F filings for Q4 2021.